The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis
Acta Neurochirurgica · 2024
DOI: 10.1007/s00701-024-06254-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Neurochirurgica, 2024. Verfasst von Basel Musmar und 41 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Thomas Jefferson University Hospital, 901 Walnut street 3rd Floor, Philadelphia, Pennsylvania, 19107, USA. Hauptthemen laut MEDLINE: Moyamoya Disease, Hypertension, Propensity Score. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Background
Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive steno-occlusive changes in the internal carotid arteries, leading to an abnormal vascular network. Hypertension is prevalent among MMD patients, raising concerns about its impact on disease outcomes. This study aims to compare the clinical characteristics and outcomes of MMD patients with and without hypertension.
Methods
We conducted a multicenter, retrospective study involving 598 MMD patients who underwent surgical revascularization across 13 academic institutions in North America. Patients were categorized into hypertensive ( n= 292) and non-hypertensive ( n= 306) cohorts. Propensity score matching (PSM) was performed to adjust for baseline differences.
Results
The mean age was higher in the hypertension group (46 years vs. 36.8 years, p < 0.001). Hypertensive patients had higher rates of diabetes mellitus (45.2% vs. 10.7%, p < 0.001) and smoking (48.8% vs. 27.1%, p < 0.001). Symptomatic stroke rates were higher in the hypertension group (16% vs. 7.1%; OR: 2.48; 95% CI: 1.39-4.40, p = 0.002) before matching. After PSM, there were no significant differences in symptomatic stroke rates (11.1% vs. 7.7%; OR: 1.5; CI: 0.64-3.47, p = 0.34), perioperative strokes (6.2% vs. 2.1%; OR 3.13; 95% CI: 0.83-11.82, p = 0.09), or good functional outcomes at discharge (93% vs. 92.3%; OR 1.1; 95% CI: 0.45-2.69, p = 0.82).
Conclusion
No significant differences in symptomatic stroke rates, perioperative strokes, or functional outcomes were observed between hypertensive and non-hypertensive Moyamoya patients. Appropriate management can lead to similar outcomes in both groups. Further prospective studies are required to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, Thomas Jefferson University Hospital, 901 Walnut street 3rd Floor, Philadelphia, Pennsylvania, 19107, USA.
- Department of Neurosurgery, University of Arizona college of medicine, Tucson, Arizona, USA.
- Department of Neurosurgery, The University of Texas Health Science Center, Houston, TX, USA.
- Department of Neurosurgery, Emory University, Atlanta, Georgia, USA.
- Department of Medical Imaging, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
- Neuroendovascular Program, Massachusetts General Hospital & Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Förderung
- NCATS NIH HHS
Zitieren
APA
Musmar, B., Roy, J. M., Abdalrazeq, H., Atallah, E., Naamani, K. E., Chen, C. J., Jabre, R., Saad, H., Grossberg, J. A., Dmytriw, A. A., Patel, A. B., Khorasanizadeh, M., Ogilvy, C. S., Thomas, A. J., Monteiro, A., Siddiqui, A., Cortez, G. M., Hanel, R. A., Porto, G., …, & Jabbour, P. (2024). The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis. Acta Neurochirurgica. https://doi.org/10.1007/s00701-024-06254-0
Vancouver
Musmar B, Roy JM, Abdalrazeq H, Atallah E, Naamani KE, Chen CJ, et al. The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis. Acta Neurochirurgica. 2024. doi:10.1007/s00701-024-06254-0
BibTeX
@article{Musmar2024,
author = {Musmar, Basel and Roy, Joanna M and Abdalrazeq, Hammam and Atallah, Elias and Naamani, Kareem El and Chen, Ching-Jen and Jabre, Roland and Saad, Hassan and Grossberg, Jonathan A and Dmytriw, Adam A and Patel, Aman B and Khorasanizadeh, Mirhojjat and Ogilvy, Christopher S and Thomas, Ajith J and Monteiro, Andre and Siddiqui, Adnan and Cortez, Gustavo M and Hanel, Ricardo A and Porto, Guilherme and Spiotta, Alejandro M and Piscopo, Anthony J and Hasan, David M and Ghorbani, Mohammad and Weinberg, Joshua and Nimjee, Shahid M and Bekelis, Kimon and Salem, Mohamed M and Burkhardt, Jan-Karl and Zetchi, Akli and Matouk, Charles and Howard, Brian M and Lai, Rosalind and Du, Rose and Abbas, Rawad and Sioutas, Georgios S and Amllay, Abdelaziz and Munoz, Alfredo and Herial, Nabeel A and Tjoumakaris, Stavropoula I and Gooch, Michael Reid and Rosenwasser, Robert H and Jabbour, Pascal},
title = {The impact of hypertension on clinical outcomes in moyamoya disease: a multicenter, propensity score-matched analysis},
journal = {Acta Neurochirurgica},
year = {2024},
doi = {10.1007/s00701-024-06254-0}
}
EUVIMED